# Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)

> **NCT02186015** · PHASE2 · COMPLETED · sponsor: **Loyola University** · enrollment: 43 (actual)

## Conditions studied

- Adult Women
- Metastatic Breast Cancer
- Estrogen Receptor Positive

## Interventions

- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT02186015
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-03-08
- **Final completion:** 2017-11-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02186015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02186015, "Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02186015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*